Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Pelzer

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Plos One|October 28, 2024
The TB vaccine clinical trial centre directory: An inventory of clinical trial centres in Sub-Saharan AfricaPuck T Pelzer, Marit Holleman, Michelle E H Helinski, et al.
Vaccine|June 10, 2026
The role of interferon-gamma release assays in tuberculosis vaccine trials: strengths, limitations, and implications beyond trial designAlemnew F Dagnew, Alexander C Schmidt, Amy Cinar, et al.
PLOS Global Public Health|March 24, 2023
Potential implementation strategies, acceptability, and feasibility of new and repurposed TB vaccinesPuck T Pelzer, Janet Seeley, Fiona Yueqian Sun, et al.
Expert Review of Vaccines|July 5, 2024
Lessons from a decade of adult vaccine rollout in low- and middle-income countries: a scoping reviewAmelia K Gerste, Arman Majidulla, Anurima Baidya, et al.
BMC Public Health|July 17, 2021
Acceptability, feasibility, and likelihood of stakeholders implementing the novel BPaL regimen to treat extensively drug-resistant tuberculosis patientsS E J van de Berg, P T Pelzer, A J van der Land, et al.
The Lancet. Respiratory Medicine|July 6, 2025
Evidence required to evaluate the use of bacteriologically confirmed asymptomatic tuberculosis disease as a primary endpoint in prevention of tuberculosis disease vaccine licensure trialsRichard G White, Gavin J Churchyard, Katherine C Horton, et al.
The Lancet. Microbe|December 22, 2024
Effectiveness of the primary Bacillus Calmette-Guérin vaccine against the risk of Mycobacterium tuberculosis infection and tuberculosis disease: a meta-analysis of individual participant dataPuck T Pelzer, Logan Stuck, Leonardo Martinez, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Plos One|October 28, 2024
The TB vaccine clinical trial centre directory: An inventory of clinical trial centres in Sub-Saharan AfricaPuck T Pelzer, Marit Holleman, Michelle E H Helinski, et al.
Vaccine|June 10, 2026
The role of interferon-gamma release assays in tuberculosis vaccine trials: strengths, limitations, and implications beyond trial designAlemnew F Dagnew, Alexander C Schmidt, Amy Cinar, et al.
PLOS Global Public Health|March 24, 2023
Potential implementation strategies, acceptability, and feasibility of new and repurposed TB vaccinesPuck T Pelzer, Janet Seeley, Fiona Yueqian Sun, et al.
Expert Review of Vaccines|July 5, 2024
Lessons from a decade of adult vaccine rollout in low- and middle-income countries: a scoping reviewAmelia K Gerste, Arman Majidulla, Anurima Baidya, et al.
BMC Public Health|July 17, 2021
Acceptability, feasibility, and likelihood of stakeholders implementing the novel BPaL regimen to treat extensively drug-resistant tuberculosis patientsS E J van de Berg, P T Pelzer, A J van der Land, et al.
The Lancet. Respiratory Medicine|July 6, 2025
Evidence required to evaluate the use of bacteriologically confirmed asymptomatic tuberculosis disease as a primary endpoint in prevention of tuberculosis disease vaccine licensure trialsRichard G White, Gavin J Churchyard, Katherine C Horton, et al.
The Lancet. Microbe|December 22, 2024
Effectiveness of the primary Bacillus Calmette-Guérin vaccine against the risk of Mycobacterium tuberculosis infection and tuberculosis disease: a meta-analysis of individual participant dataPuck T Pelzer, Logan Stuck, Leonardo Martinez, et al.
Pageof 4